Decision Diagnostics Price To Earning vs. Price To Sales

DECN Stock  USD 0.0001  0.00  0.00%   
Based on Decision Diagnostics' profitability indicators, Decision Diagnostics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Decision Diagnostics' ability to earn profits and add value for shareholders. As of the 29th of November 2024, Sales General And Administrative To Revenue is likely to grow to 1.36, while Price To Sales Ratio is likely to drop 2.65. At this time, Decision Diagnostics' Income Tax Expense is very stable compared to the past year. As of the 29th of November 2024, Change To Netincome is likely to grow to about 33.4 M, while Operating Income is likely to drop (2 M).
For Decision Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Decision Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Decision Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Decision Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Decision Diagnostics over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Decision Diagnostics Price To Sales vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Decision Diagnostics's current stock value. Our valuation model uses many indicators to compare Decision Diagnostics value to that of its competitors to determine the firm's financial worth.
Decision Diagnostics is rated # 3 in price to earning category among its peers. It is rated below average in price to sales category among its peers . At this time, Decision Diagnostics' Price To Sales Ratio is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Decision Diagnostics' earnings, one of the primary drivers of an investment's value.

Decision Price To Sales vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Decision Diagnostics

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
(0.33) X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Decision Diagnostics

P/S

 = 

MV Per Share

Revenue Per Share

 = 
0.02 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Decision Price To Sales Comparison

Decision Diagnostics is currently under evaluation in price to sales category among its peers.

Decision Diagnostics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Decision Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Decision Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of Decision Diagnostics' change in net profit over the period of time. It can combine multiple indicators of Decision Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-1.9 M-2 M
Net Loss-26.7 M-25.4 M
Income Before Tax-26.7 M-25.4 M
Total Other Income Expense Net-347.5 K-364.9 K
Net Loss-26.7 M-25.4 M
Net Loss-26.7 M-25.4 M
Income Tax Expense3.1 K3.3 K
Net Interest Income-24.5 M-23.3 M
Change To Netincome31.8 M33.4 M
Net Loss(0.10)(0.11)
Income Quality 0.04  0.04 
Net Income Per E B T 1.15  0.81 

Decision Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Decision Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Decision Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Decision Diagnostics' important profitability drivers and their relationship over time.

Use Decision Diagnostics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Decision Diagnostics Pair Trading

Decision Diagnostics Pair Trading Analysis

The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Decision Diagnostics position

In addition to having Decision Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Services Thematic Idea Now

Services
Services Theme
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Check out Investing Opportunities.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
To fully project Decision Diagnostics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Decision Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Decision Diagnostics' income statement, its balance sheet, and the statement of cash flows.
Potential Decision Diagnostics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Decision Diagnostics investors may work on each financial statement separately, they are all related. The changes in Decision Diagnostics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Decision Diagnostics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.